Clinical utility and prognostic value of galactomannan in neutropenic patients with invasive aspergillosis

Pathologie Biologie

Volumn 60, Issue 6, 2012, Pages 357-361

  Hadrich, I ^a   Makni, F ^a   Cheikhrouhou, F ^a   Neji, S ^a   Amouri, I ^a   Sellami, H ^a   Trabelsi, H ^a   Bellaaj, H ^b   Elloumi, M ^b   Ayadi, A ^a  

^a UNIVERSITY OF SFAX   (Tunisia)

^b HEDI CHAKER HOSPITAL   (Tunisia)

Author keywords

Galactomannan; Invasive aspergillosis; Pronostic value

Indexed keywords

AMPHOTERICIN B; GALACTOMANNAN; VORICONAZOLE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMATOLOGIC MALIGNANCY; HUMAN; IMMUNOCOMPROMISED PATIENT; INVASIVE ASPERGILLOSIS; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; PATIENT MONITORING; PRESCHOOL CHILD; PROGNOSIS; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; BRONCHOALVEOLAR LAVAGE FLUID; CHILD; COHORT STUDIES; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; IMMUNOCOMPROMISED HOST; INFANT; INVASIVE PULMONARY ASPERGILLOSIS; MALE; MANNANS; MIDDLE AGED; NEUTROPENIA; PROGNOSIS; SENSITIVITY AND SPECIFICITY;

EID: 84870393389     PISSN: 03698114     EISSN: 17683114     Source Type: Journal    
DOI: 10.1016/j.patbio.2011.10.011     Document Type: Article

References (20)

1. Jantunen E., Ruutu P., Niskanen L., et al. Incidence and risk factors for invasive fungal infections in allogeneic BMT recipients. Bone Marrow Transplant 1997, 19:801-808.
2. Maertens J., Verhaegen J., Lagrou K., Van Eldere J., Boogaerts M. Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation. Blood 2001, 97:1604-1610.
3. Denning D.W., Stevens D.A. Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases. Rev Infect Dis 1990, 12:1147-1201.
4. Caillot D., Couaillier J.F., Bernard A., et al. Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia. J Clin Oncol 2001, 19:253-259.
5. Vandewoude K.H., Blot S.I., Depuydt P., et al. Clinical relevance of Aspergillus isolation from respiratory tract samples in critically ill patients. Crit Care 2006, 10:R31.
6. Yeo S.F., Wong B. Current status of nonculture methods for diagnosis of invasive fungal infections. Clin Microbiol Rev 2002, 15:465-484.
7. Persat F., Ranque S., Derouin F., Michel-Nguyen A., Picot S., Sulahian A. Contribution of the (1-->3)-beta-D-glucan assay for diagnosis of invasive fungal infections. J Clin Microbiol 2008, 46:1009-1013.
8. Woods G., Miceli M.H., Grazziutti M.L., Zhao W., Barlogie B., Anaissie E. Serum Aspergillus galactomannan antigen values strongly correlate with outcome of invasive aspergillosis: a study of 56 patients with hematologic cancer. Cancer 2007, 110:830-834.
9. Koo S., Bryar J.M., Baden L.R., Marty F.M. Prognostic features of galactomannan antigenemia in galactomannan-positive invasive aspergillosis. J Clin Microbiol 2010, 48:1255-1260.
10. De Pauw B., Walsh T.J., Donnelly J.P., et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008, 46:1813-1821.
11. Maertens J., Theunissen K., Verbeken E., et al. Prospective clinical evaluation of lower cut-offs for galactomannan detection in adult neutropenic cancer patients and haematological stem cell transplant recipients. Br J Haematol 2004, 126:852-860.
12. Yao J.F., Su D., Huang Y., et al. Circulating galactomannan screening for early diagnosis and treatment of invasive aspergillosis. Zhonghua Xue Ye Xue Za Zhi 2009, 30:592-595.
13. Sarrafzadeh S.A., Hoseinpoor Rafati A., Ardalan M., Mansouri D., Tabarsi P., Pourpak Z. The accuracy of serum galactomannan assay in diagnosing invasive pulmonary aspergillosis. Iran J Allergy Asthma Immunol 2010, 9:149-155.
14. Maertens J., Maertens V., Theunissen K., et al. Bronchoalveolar lavage fluid galactomannan for the diagnosis of invasive pulmonary aspergillosis in patients with hematologic diseases. Clin Infect Dis 2009, 49:1688-1693.
15. Nguyen M.H., Leather H., Clancy C.J., et al. Galactomannan testing in bronchoalveolar lavage fluid facilitates the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies and stem cell transplant recipients. Biol Blood Marrow Transplant 2011, 17:1042-1050.
16. Park S.Y., Lee S.O., Choi S.H., et al. Aspergillus galactomannan antigen assay in bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis. J Infect 2010, 61:492-498.
17. Reichenberger F., Habicht J., Matt P., et al. Diagnostic yield of bronchoscopy in histologically proven invasive pulmonary aspergillosis. Bone Marrow Transplant 1999, 24:1195-1199.
18. Luong M.L., Filion C., Labbe A.C., et al. Clinical utility and prognostic value of bronchoalveolar lavage galactomannan in patients with hematologic malignancies. Diagn Microbiol Infect Dis 2010, 68:132-139.
19. Hope W.W., Kruhlak M.J., Lyman C.A., et al. Pathogenesis of Aspergillus fumigatus and the kinetics of galactomannan in an in vitro model of early invasive pulmonary aspergillosis: implications for antifungal therapy. J Infect Dis 2007, 195:455-466.
20. Mennink-Kersten M.A., Donnelly J.P., Verweij P.E. Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis. Lancet Infect Dis 2004, 4:349-357.